Locations:
Search IconSearch

Tag: COVID-19 vaccine

COVID-19 vaccine vials
March 30, 2023/Digestive/Research

Vaccination Mitigates Increased Risk of COVID Hospitalization in Celiac Patients, Study Finds

Results from the large, single-center, retrospective study have multiple implications for preventive care

Vaccine

Where We’re Headed with Vaccine Research: A Conversation with Ted Ross, PhD

Cleveland Clinic’s new Global Director of Vaccine Development outlines plans, priorities

22-NUR-3058679-Expand-Roles-Retired-Nurses-beyond-1-CQD_650x450

Retired Nurses Lend a Hand by Putting Their Expertise to “Work”

Retiree group provides vaccines, administers tests amid pandemic-related surge

Vaccine supply
January 5, 2022/COVID-19

‘Most Unvaccinated People Are Not Anti-Vaxxers’

Ob/Gyn explains how she helps patients overcome COVID-19 vaccine hesitancy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Vaccine
December 2, 2021/COVID-19

How to Address Common COVID-19 Vaccine Myths With Patients

Experts address myths about long-term effects, fertility concerns and more

Covid-19 vaccine vials
September 30, 2021/COVID-19

COVID-19 Vaccines in Patients with Immune-Mediated Inflammatory Diseases

Clinical guidance for our most vulnerable patients

Blood clot
April 26, 2021/COVID-19

Rare Thrombosis Linked to J&J Vaccine: What to Look For, How to Manage It

Essentials of cerebral venous sinus thrombosis from a neurointensive care/stroke specialist

21-NEU-2079842_COVID-19-in-MS-patients_650x450
March 29, 2021/COVID-19

Registry Study Pinpoints Risk Factors for Worse COVID-19 Outcomes in Patients With MS

Ambulation disability carries greatest risk, most disease-modifying therapies aren’t implicated

Covid vaccine
March 18, 2021/COVID-19

Tackling COVID-19 Patient Vaccine Distribution Challenges with Health Information Technology

Tech-driven automation improves patient experience, care efficiency

21-CCC-2076492 SARS-CoV-2

Nanoparticle-Delivered COVID-19 Vaccine Candidate Shows Promise in Preclinical Studies

Universally produced neutralizing antibodies, may offer thermostability

BackPage 1 of 2Next

Advertisement

Ad